Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GC Pharma Aiming To Outrun Rivals For COVID-19 Plasma Therapy

Korean Firm Plans Trial Start Soon

Apr 09 2020

• By Jung Won Shin

Coronavirus — GC Pharma Pursuing Rapid COVID-19 R&D • Source: Shutterstock

Related Content

Korean Pharma Accelerates Coronavirus-Related R&D, Calls For More Support

Mar 09 2020

Takeda, CSL, Other Blood Plasma Firms Team On Hyperimmune COVID-19 Therapy

Apr 06 2020

Coronavirus Update: Drug Shortages On Horizon, Firms Offer Medical Staff For The Fight, More Studies Start

Apr 02 2020

Related Companies

GC Biopharma Corp.

Takeda Pharmaceutical Co. Ltd.

Grifols, S.A.

CSL Limited

Octapharma AG

Biotest AG

LFB Group

Kleo Pharmaceuticals Inc.

Celltrion, Inc.

Additional Topics

South Korea Asia Pacific Coronavirus COVID-19 Research & Development BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window